The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
Fucà G, Beninato T, Bini M, Mazzeo L, Di Guardo L, Cimminiello C, Randon G, Apollonio G, Bisogno I, Del Vecchio M, Lauria Pantano C, Di Nicola M, de Braud F, Del Vecchio M.
Fucà G, et al. Among authors: cimminiello c.
Target Oncol. 2021 Jul;16(4):529-536. doi: 10.1007/s11523-021-00819-0. Epub 2021 Jun 2.
Target Oncol. 2021.
PMID: 34076798